GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $866,000 | -0.5% | 20,078 | 0.0% | 0.05% | -2.1% |
| Q2 2016 | $870,000 | -4.9% | 20,078 | -11.1% | 0.05% | -2.1% |
| Q1 2016 | $915,000 | +0.4% | 22,577 | 0.0% | 0.05% | -9.4% |
| Q4 2015 | $911,000 | -7.5% | 22,577 | -11.9% | 0.05% | -14.5% |
| Q3 2015 | $985,000 | -7.7% | 25,629 | 0.0% | 0.06% | +8.8% |
| Q2 2015 | $1,067,000 | +2.4% | 25,629 | +13.5% | 0.06% | +1.8% |
| Q1 2015 | $1,042,000 | +8.0% | 22,582 | 0.0% | 0.06% | +7.7% |
| Q4 2014 | $965,000 | -7.0% | 22,582 | 0.0% | 0.05% | -10.3% |
| Q3 2014 | $1,038,000 | +2.9% | 22,582 | +19.6% | 0.06% | +3.6% |
| Q2 2014 | $1,009,000 | +0.1% | 18,874 | 0.0% | 0.06% | -3.4% |
| Q1 2014 | $1,008,000 | 0.0% | 18,874 | 0.0% | 0.06% | +11.5% |
| Q4 2013 | $1,008,000 | +16.4% | 18,874 | +9.3% | 0.05% | +6.1% |
| Q3 2013 | $866,000 | +9.5% | 17,271 | +9.1% | 0.05% | +2.1% |
| Q2 2013 | $791,000 | – | 15,831 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |